Litcius/Paper detail

Long-term Prognosis of Patellar Tendinopathy (Jumper’s Knee) in Young, Elite Volleyball Players: Tendon Changes 11 Years After Baseline

Håvard Visnes, Lena Kristin Bache‐Mathiesen, Tetsuo Yamaguchi, Hans Petter Gilhuus, Knut Robert Hector Algaard, Erling Hisdal, Roald Bahr

2024The American Journal of Sports Medicine12 citationsDOIOpen Access PDF

Abstract

Background: The long-term prognosis of jumper's knee and whether structural changes in the patellar tendon persist is unknown. Purpose: To investigate whether limitations in knee function and structural changes persisted beyond the athletic career of young elite volleyball players. Study Design: Cohort study; Level of evidence, 2. Methods: Volleyball players (mean ± SD age, 18 ± 0.8 years) enrolled in 2006-2011 in a prospective cohort study were invited in 2020-2022 to a follow-up study. Participants rated their knee function with the Victorian Institute of Sport Assessment–Patellar Tendon (VISA-P) score (baseline and follow-up) and the International Knee Documentation Committee (IKDC) score (follow-up) and reported if jumper's knee had influenced their decision to retire from sport. Tendon thickness and structural changes were assessed with ultrasound (baseline) and magnetic resonance imaging (MRI) (follow-up) of both patellar tendons. Results: We included 138 of 143 former athletes (97%) 11.4 ± 1.6 years after their baseline examination. At baseline, 37 persons (52 knees) had developed jumper's knee. At follow-up, participants reported lower knee function scores in knees diagnosed with jumper's knee at baseline than healthy knees (VISA-P scores: jumper's knee, 81 [95% CI, 70-92]; healthy, 90 [95% CI, 86-94]; P < .001; IKDC scores: jumper's knee, 82 [95% CI, 75-89]; healthy, 92 [95% CI, 91-95]; P < .001). Jumper's knee problems directly caused 7 of the 37 athletes (19%) with jumper's knee at baseline to retire from competitive volleyball. Of the 138 players included, 97 (70%) completed a bilateral MRI examination (194 knees). At follow-up, 38 of the 54 abnormal tendons (70%) had no structural changes ( P < .001 vs baseline) while 22 of the 140 normal tendons (16%) had developed structural changes. Clinical symptoms were not correlated with tendon structure at follow-up (VISA-P scores for normal tendons: 85 [95% CI, 73-87]; abnormal: 89 [95% CI, 85-92]; P = .48). Conclusion: Jumper’s knee is not a self-limiting condition; volleyball players who had developed jumper's knee during adolescence reported persistent reductions in knee function 11 years later, leading one-fifth to retire from competitive volleyball. Although approximately 70% of tendons with structural changes at baseline were normal at follow-up, there was no clear relationship between structure and function.

Topics & Concepts

JumperMedicinePhysical therapyAthletesCohortPatellaKnee painSurgeryInternal medicineOsteoarthritisPathologyComputer scienceOperating systemAlternative medicineTendon Structure and TreatmentShoulder Injury and TreatmentLower Extremity Biomechanics and Pathologies
Long-term Prognosis of Patellar Tendinopathy (Jumper’s Knee) in Young, Elite Volleyball Players: Tendon Changes 11 Years After Baseline | Litcius